Ocuphire Pharma Inc.

NASDAQ: OCUP · Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.46 -6.51 3.93 -0.98
PEG Ratio
-0.00 0.04 -0.03 0.02
PS Ratio
n/a 3.41 1.77 94.06
PB Ratio
3.89 1.30 1.52 2.49
P/FCF Ratio
-1.02 -58.44 4.92 -2.85
P/OCF Ratio
-1.02 -58.44 4.92 -2.86
OCF/S Ratio
n/a -0.06 0.36 -32.89
Debt / Equity Ratio
n/a n/a n/a 0.02
Quick Ratio
3.24 13.35 17.79 6.76
Current Ratio
3.24 13.35 17.79 6.76
Asset Turnover
n/a 0.35 0.81 0.02
Interest Coverage
n/a n/a 2.03K -11.35K
Return on Equity
-8.56 -0.2 0.39 -2.54
Return on Assets
-1.56 -0.19 0.37 -2.17
Return on Invested Capital
-2.43 -0.21 0.39 -0.99
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 1.00 1.00 0.99
Net Profit Margin
n/a -0.52 0.45 -95.98
Pretax Profit Margin
n/a -0.52 0.46 -96.25
Operating Profit Margin
n/a -0.55 0.46 -38.55
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -0.52 0.46 -96.24